Evidence map›Paper›PMID 22325039›Full record

SynthesisInternational wound journal2013

Insulin and hypertonic glucose in the management of aseptic fat liquefaction of post-surgical incision: a meta-analysis and systematic review.

Zhongjie Shi, Lin Ma, Hao Wang, Yuebo Yang, Xiaomao Li, Ann Schreiber, Wenjing Sun, Zhanliang Hu, Yuhua Xue, Jiafeng Teng and 2 more

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International wound journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Zhongjie ShiDepartment of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA. zhongjie.shi@jefferson.edu
Lin Ma
Hao Wang
Yuebo Yang
Xiaomao Li
Ann Schreiber
Wenjing Sun
Zhanliang Hu
Yuhua Xue
Jiafeng Teng
Xuan Zhao
Wenli Lu
Harbin Medical University · CNSun Yat-sen University · CNFudan University · CNTemple University · USThird Affiliated Hospital of Sun Yat-sen University · CNThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A meta-analysis and systematic review assessing randomised controlled trials (RCTs) was sought to determine whether subcutaneous injection of insulin with hypertonic glucose promotes healing in postoperative incisions with aseptic fat liquefaction. We searched the Cochrane library, Pubmed, EMBASE, National Science Digital Library (NSDL) and China Biological Medicine Database (CBMdisc) for literature published from 1 January 1990 to 30 September 2011. RCTs that evaluated subcutaneous injection of insulin with hypertonic glucose as a treatment for postoperative wound with fat liquefaction were sought. Wound healing was the primary endpoint. Jadad score and Cochrane Collaboration's tool were used for assessing quality of studies and risk of bias. We abstracted data regarding time to wound healing, cost and adverse effects. The random-effects inverse variance model was used for all analyses using weighted mean difference and 95% confidence interval. Eight trials (414 participants) were identified that met the inclusion criteria. Subcutaneous injection of insulin with hypertonic glucose significantly reduces time to healing by 6·33 days compared with conventional drainage, with less cost. There was no report concerning adverse effects. Subcutaneous injection of insulin with hypertonic glucose may improve the healing process in postoperative wounds with aseptic fat liquefaction.

Indexed as

Cost-Benefit AnalysisDrug CombinationsFat NecrosisGlucose Solution, HypertonicHumansHypoglycemic AgentsInjections, SubcutaneousInsulinPostoperative ComplicationsRandomized Controlled Trials as TopicWound HealingWounds and InjuriesDrug CombinationsGlucose Solution, HypertonicHypoglycemic AgentsInsulin

Identifiers

PMID22325039
PMCPMC7950496
OpenAlexW2120070549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.